Dubai-based Amaani has closed a $5 million Series A to scale its haircare and skincare brand Aïza across the Gulf and into additional export markets, with regional VC BECO Capital leading the round and US consumer-focused Homegrown Ventures joining as a new investor.

The capital marks the company's first institutional round at Series A size, according to the disclosure. Aïza positions itself as a cultural and ingredient-led label, with haircare and skincare lines oriented around formulations drawing on regional and Middle Eastern heritage inputs.

What will the $5 million fund?

Amaani has framed the proceeds as growth capital for retail expansion across the GCC and for laying groundwork for launches outside the region. For a brand at this stage, a $5M Series A typically covers a 12-18 month runway: distribution deals, formulation extension, marketing spend, and the working capital required to onboard larger retail accounts.

The geographic sequencing, Gulf first and then cross-border, mirrors a pattern several regional indie beauty operators have followed after proving velocity inside GCC e-commerce and pharmacy channels. For procurement teams and retail buyers, the next moves to watch are shelf entries in the UAE's major beauty multiples and pharmacy chains, plus dedicated direct-to-consumer logistics for Saudi Arabia.

How does the investor line-up shape the next phase?

BECO Capital's lead position signals continued regional VC conviction in consumer brands that pair cultural relevance with commercial scale, rather than purely digitally native plays. Homegrown Ventures brings US consumer expertise to the table. The mix gives Amaani both a regional platform investor and a partner whose transatlantic distribution patterns can support an eventual US entry.

For indie founders across MENA, the round reads as another data point that homegrown beauty can attract growth-stage capital at meaningful ticket sizes, rather than relying solely on angel checks or bootstrapping through the first three years of trade marketing.

What does ingredient-led positioning mean for formulations?

Aïza describes its range as cultural and ingredient-led, a framing that in the Gulf context typically points to actives and botanicals familiar to regional consumers: oud, rose, saffron, camel milk, argan derivatives, date-seed extracts. These almost always sit on top of modern functional backbones such as mild surfactants, ceramides, and humectant systems compliant with Gulf regulatory norms.

For formulators and contract manufacturers the real commercial question is whether ingredient-led storytelling translates to clinically substantiated performance claims. The next 12 months will likely show whether Aïza can pair its cultural narrative with the kind of instrumental studies, corneometry, sebumetry, consumer panels run under UAE or Saudi protocols, that increasingly differentiate premium positioning on the region's prestige shelves.

Compliance and category watch-points

The Saudi Food and Drug Authority's cosmetic notification regime and the UAE's MoIAT product safety rules will both govern any cross-border SKUs. Amaani's Gulf-first sequencing reduces near-term regulatory friction but does not eliminate it: Saudi requires SFDA notification per product and per responsible person, and label claims must clear local advertising standards before any Gulf-wide marketing push.

Key data points to track in the coming year: confirmed GCC retail partnerships, Aïza's first published clinical or consumer-test results on its hero SKUs, and any Saudi-based manufacturing agreement that would localize production for the kingdom's market.

A first cross-border shipment outside the GCC is the milestone most likely to reshape both the brand's reformulation priorities and its compliance workload before the next fundraising window opens.